Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Trapping and Characterization of Nontoxic Aβ42 Aggregation Intermediates.

Foley AR, Finn TS, Kung T, Hatami A, Lee HW, Jia M, Rolandi M, Raskatov JA.

ACS Chem Neurosci. 2019 Aug 21;10(8):3880-3887. doi: 10.1021/acschemneuro.9b00340. Epub 2019 Aug 1.

PMID:
31319029
2.

Chirality Dependence of Amyloid β Cellular Uptake and a New Mechanistic Perspective.

Dutta S, Finn TS, Kuhn AJ, Abrams B, Raskatov JA.

Chembiochem. 2019 Apr 15;20(8):1023-1026. doi: 10.1002/cbic.201800708. Epub 2019 Feb 27.

PMID:
30550626
3.

Effect of body mass index and ertapenem versus cefotetan prophylaxis on surgical site infection in elective colorectal surgery.

Itani KM, Jensen EH, Finn TS, Tomassini JE, Abramson MA.

Surg Infect (Larchmt). 2008 Apr;9(2):131-7. doi: 10.1089/sur.2007.034.

PMID:
18426345
4.

Polyethylene glycol versus sodium phosphate mechanical bowel preparation in elective colorectal surgery.

Itani KM, Wilson SE, Awad SS, Jensen EH, Finn TS, Abramson MA.

Am J Surg. 2007 Feb;193(2):190-4.

PMID:
17236845
5.

Ertapenem versus cefotetan prophylaxis in elective colorectal surgery.

Itani KM, Wilson SE, Awad SS, Jensen EH, Finn TS, Abramson MA.

N Engl J Med. 2006 Dec 21;355(25):2640-51.

6.

Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.

Haas DW, Johnson B, Nicotera J, Bailey VL, Harris VL, Bowles FB, Raffanti S, Schranz J, Finn TS, Saah AJ, Stone J.

Antimicrob Agents Chemother. 2003 Jul;47(7):2131-7.

7.

Open-label study of a twice-daily indinavir 800-mg/ritonavir 200-mg regimen in HIV-infected adults failing a protease inhibitor regimen.

Katner HP, Paar DP, Nadler JP, Jensen EH, Wilson HM, Finn TS, Petruschke RA, Zeldin RK.

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):483-7.

PMID:
12473836
8.

Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults.

Young B, Fischl MA, Wilson HM, Finn TS, Jensen EH, DiNubile MJ, Zeldin RK.

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):478-82.

PMID:
12473835
9.

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.

Lim JT, Piazza GA, Han EK, Delohery TM, Li H, Finn TS, Buttyan R, Yamamoto H, Sperl GJ, Brendel K, Gross PH, Pamukcu R, Weinstein IB.

Biochem Pharmacol. 1999 Oct 1;58(7):1097-107.

PMID:
10484067

Supplemental Content

Support Center